BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,429 | -100.0% | 201,845 | -64.3% | 0.00% | -80.0% |
| Q3 2022 | $7,124,000 | +432.4% | 565,380 | +347.0% | 0.01% | +400.0% |
| Q2 2022 | $1,338,000 | -67.3% | 126,480 | -49.7% | 0.00% | -60.0% |
| Q1 2022 | $4,089,000 | -30.3% | 251,480 | -38.4% | 0.01% | -37.5% |
| Q3 2021 | $5,866,000 | -64.1% | 408,180 | -60.5% | 0.01% | -60.0% |
| Q2 2021 | $16,324,000 | +2279.6% | 1,032,480 | +1430.3% | 0.02% | +1900.0% |
| Q1 2021 | $686,000 | -92.8% | 67,470 | -94.7% | 0.00% | -90.0% |
| Q4 2020 | $9,539,000 | +228.8% | 1,280,380 | +52.3% | 0.01% | +400.0% |
| Q4 2019 | $2,901,000 | +380.3% | 840,734 | +298.8% | 0.00% | +100.0% |
| Q3 2019 | $604,000 | -63.5% | 210,815 | -2.9% | 0.00% | -50.0% |
| Q3 2018 | $1,657,000 | -72.0% | 217,203 | -81.3% | 0.00% | -33.3% |
| Q2 2018 | $5,923,000 | +61.7% | 1,162,384 | +51.4% | 0.00% | -25.0% |
| Q1 2018 | $3,662,000 | +88.3% | 767,803 | +93.8% | 0.00% | +100.0% |
| Q4 2017 | $1,945,000 | +63.9% | 396,203 | +74.9% | 0.00% | +100.0% |
| Q3 2017 | $1,187,000 | -47.2% | 226,503 | -44.0% | 0.00% | -66.7% |
| Q2 2017 | $2,249,000 | +22.2% | 404,503 | +84.5% | 0.00% | 0.0% |
| Q1 2017 | $1,841,000 | +482.6% | 219,203 | +339.3% | 0.00% | – |
| Q4 2016 | $316,000 | -61.8% | 49,903 | -82.9% | 0.00% | -100.0% |
| Q1 2016 | $827,000 | -43.9% | 292,221 | +104.5% | 0.00% | -33.3% |
| Q4 2015 | $1,475,000 | +403.4% | 142,903 | +341.0% | 0.00% | +200.0% |
| Q1 2015 | $293,000 | -69.4% | 32,403 | -64.2% | 0.00% | -50.0% |
| Q1 2014 | $958,000 | – | 90,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 3,926,700 | $56,427,000 | 4.43% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $27,601,000 | 3.44% |
| HealthCor Management, L.P. | 3,849,470 | $55,317,000 | 2.39% |
| MPM BioImpact LLC | 704,767 | $10,128,000 | 1.57% |
| Baker Brothers Advisors | 12,710,818 | $182,654,000 | 0.80% |
| Bain Capital Public Equity Management II, LLC | 1,472,471 | $21,159,000 | 0.74% |
| Biondo Investment Advisors, LLC | 267,480 | $3,844,000 | 0.66% |
| North Star Investment Management Corp. | 442,900 | $6,364,000 | 0.52% |
| DOLIVER ADVISORS, LP | 100,000 | $1,437,000 | 0.48% |
| Lisanti Capital Growth, LLC | 219,450 | $3,153,000 | 0.46% |